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Background: The BRC repeat is essential for BRCA2 to bind RAD51 and promote homologous recombination.
Results: A BRC repeat variant is essential for RECQL5 to bind RAD51 and suppress homologous recombination.
Conclusion: The BRC repeat can be utilized to either promote or suppress homologous recombination.
Significance: Discovery of multiple functions of the BRC repeat is important for understanding regulation of homologous
recombination.
The BRC repeat is a structural motif in the tumor suppressor
BRCA2 (breast cancer type 2 susceptibility protein), which pro-
motes homologous recombination (HR) by regulating RAD51
recombinase activity. To date, the BRC repeat has not been
observed in other proteins, so that its role in HR is inferred only
in the context of BRCA2. Here, we identified a BRC repeat var-
iant, named BRCv, in the RECQL5 helicase, which possesses
anti-recombinase activity in vitro and suppresses HR and pro-
motes cellular resistance to camptothecin-induced replication
stress in vivo. RECQL5-BRCv interacted with RAD51 through
two conserved motifs similar to those in the BRCA2-BRC
repeat. Mutations of either motif compromised functions of
RECQL5, including association with RAD51, inhibition of
RAD51-mediated D-loop formation, suppression of sister chro-
matid exchange, and resistance to camptothecin-induced repli-
cation stress. Potential BRCvs were also found in other HR
regulatory proteins, including Srs2 and Sgs1, which possess
anti-recombinase activities similar to that of RECQL5. A point
mutation in the predicted Srs2-BRCvdisrupted the ability of the
protein to bind RAD51 and to inhibit D-loop formation. Thus,
BRC is a common RAD51 interaction module that can be uti-
lized by different proteins to either promoteHR, as in the case of
BRCA2, or to suppress HR, as in RECQL5.
Homologous recombination (HR)3 is critical for the error-
free repair of chromosomal lesions, such as DNAdouble strand
breaks, and also for the recovery of damaged replication forks
(1, 2). During meiosis, HR generates crossovers among homol-
ogous chromosomes to ensure their proper segregation at the
first meiotic division (1, 3). Thus, HR is indispensable for the
maintenance of genome integrity and meiotic chromosome
segregation (4). In fact, defects in HR can increase cancer and
failedmeiosis (4). On the other hand, untimely and inappropri-
ateHRcan cause gross chromosome rearrangements, including
translocations, deletions, and inversions, with potentially
mutagenic or oncogenic consequences (2, 4). Therefore, HR is
tightly controlled in cells by a variety of pro- and anti-recombi-
nogenic regulatory mechanisms.
Human BRCA2 and its orthologs are an important positive
regulatory element forHR (5–7). BRCA2 directly interacts with
RAD51 recombinase and recruits it to double strand breaks.
BRCA2 promotes the formation of the RAD51-ssDNA nucleo-
protein filament that pairs with and invades a homologous
DNA duplex to initiate homologous DNA repair. Moreover,
BRCA2 modulates the DNA binding selectivity of RAD51 to
stimulate strand exchange (8, 9). The primary RAD51 interac-
tion domain in BRCA2 and its orthologs consists of a varying
number of the BRC repeat, a module of 35 amino acid resi-
dues (10, 11). The BRC repeat directly associates with RAD51
or RAD51-DNA filaments, regulates the DNA binding activity
of RAD51, enhances the exchange of the ssDNA-binding factor
replication protein A (RPA) by RAD51 on ssDNA, and pro-
motes RAD51-dependent homologous DNA pairing (8, 9, 12,
13). Structural and functional analyses have revealed that the
BRC repeat harbors twomotifs, referred to asmotif 1 andmotif
2, which are separated by a linker sequence (11, 14). Motif 1
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binds the oligomerization interface of RAD51 to regulate
RAD51 filament assembly, whereas motif 2 binds a separate
region of RAD51, and a functional BRC repeat requires the two
motifs working in tandem pairs (14).
To date, the BRC repeat has not been discovered in any other
proteins, but we report here its presence in RECQL5, where it
also regulates HR. RECQL5 is one of five RecQ-like DNA heli-
cases inmammalian cells (15, 16). Genetic studies inmouse and
chicken DT40 cells have implicated RECQL5 in the suppres-
sion of HR, including inhibition of sister chromatid exchange
(SCE) (17, 18), in the preservation of genome integrity upon
genotoxic stress (19) and in cancer avoidance (20). RECQL5
directly interacts with RAD51 and inhibits RAD51-mediated
homologous DNA pairing by dismantling the RAD51 presyn-
aptic filament assembled on ssDNA (20, 21). A previous study
has mapped a RAD51-interacting region between residues 654
and 725 of RECQL5 and shown that several residues within this
region are important for binding and regulation of RAD51
recombinase in vitro and for HR regulation in vivo (21). How-
ever, the region was not defined as a recognizable domain.
Here, we show that the RAD51 interaction domain in RECQL5
consists of two motifs with a strong resemblance to the con-
served motifs found in the BRCA2-BRC repeats. We have
named this RECQL5 domain BRCv (BRC variant) because it
also harbors notable differences from the BRC repeats in
BRCA2. Importantly, we demonstrate that both motifs of
BRCv are required for RECQL5 to interact with RAD51, to
inhibit RAD51-mediated homologous DNA pairing, to sup-
press SCE, and to tolerate replication stress. Sequence-based
comparisons reveal that potential BRCvs are present in other
HR regulatory proteins, suggesting that the BRC repeat and
its variants may be employed by many proteins in the regu-
lation of HR.
EXPERIMENTAL PROCEDURES
Cell Culture—Chicken DT40 cell lines were maintained in
RPMImedium (Invitrogen) supplemented with 10% heat-inac-
tivated fetal bovine serum, 1% chicken serum, 1.5% penicillin-
streptomycin (Invitrogen), and 10 mM HEPES (pH 7.9). HEK-
293 cells were grown in DMEM containing 10% fetal bovine
serum.
Antibodies—RAD51 (H-92) and RAD51 (ab63801) antibod-
ies were obtained from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA) and Abcam, respectively. Anti-FLAG M2 and RNA
polymerase II (Pol II) (ARNA-3) monoclonal antibodies were
obtained from Sigma and Fitzgerald, respectively.
Protein Purification—Wild-type andmutant forms of human
RECQL5 were expressed in Escherichia coli and purified as
described previously (20). Human RAD51 K133R, RPA, and
HOP2-MND1 complex were purified according to previously
published protocols (22, 23). Wild type and mutant forms of
Srs2 were expressed in E. coli and purified as described (24, 25).
Yeast Rad51 protein was expressed in yeast cells and purified as
described (26).
Immunoprecipitation—RecQL5-associated complexes were
isolated from total cell lysate of HEK-293 cells transiently
expressing FLAG-tagged RECQL5 (FRECQL5). Cell pellets
were suspended in three volumes of lysis buffer (50 mM Tris-
HCl (pH 8.0), 150 mM NaCl, 5 mM MgCl2, and 0.5% Nonidet
P-40) containing 1 mM PMSF, 1 mM DTT, and protease inhib-
itor mixture. FLAG immunoprecipitation (IP) was done
according to the manufacturer’s protocol (Sigma). In brief, cell
lysates were diluted three times with lysis buffer and incubated
with anti-FLAGM2-agarose affinity gel for at least 12 h at 4 °C.
The resin was washed three times for 10 min each with lysis
buffer and then treated with the FLAG peptide to elute pro-
teins. The eluate was subjected to immunoblotting.
Affinity Pull-down—His9-tagged wild type or mutant Srs2
was incubated with yeast Rad51 in 30 l of buffer (25 mM Tris-
HCl, pH 7.5, 0.01% Igepal, 1mM2-mercaptoethanol, and 10mM
imidazole) containing 100mMKCl for 30 min at 4 °C and then
mixed with 10 l of Ni-NTA-agarose (Qiagen) for 2 h at 4 °C
to capture the tagged Srs2 and Rad51. The resin was washed
three times with 50 l of the same buffer and then treated
with 20 l of 2% SDS to elute proteins. The supernatant, last
wash, and SDS eluate (10 l each) were analyzed by
SDS-PAGE.
ATPase Assay—The ATPase assay was carried out as
described (20). Briefly, RECQL5 or one of the indicated
RECQL5 mutants (25 nM) was incubated with X174 ssDNA
(75 M nucleotides) and 1.5 mM [-32P]ATP for the indicated
times. For wild type and mutant Srs2, 15 nM proteins was used.
Analysis was done by thin layer chromatography (20).
D-loopAssay—Thiswas conducted at 37 °C as described (20),
by incubating the RAD51-K133R protein (1 M) with radioac-
tively labeled 90-mer oligonucleotide D1 (3Mnucleotides) for
5 min, followed by the incorporation of RPA (135 nM) together
with RECQL5 or the indicated RECQL5 mutant (25 nM) and a
5-min incubation. Then HOP2-MND1 (300 nM) and pBlue-
script replicative form I DNA (50 M base pairs) were added to
complete the reaction. After 10 min of incubation, the reaction
mixtures were deproteinized and analyzed, as described (20).
The D-loop assay for wild type and mutant forms of Srs2 was
conducted according to Ref. 24.
Complementation Analyses—Complementation analyses
were done as described previously (27) with some modifica-
tions. In brief, FLAG-tagged RECQL5 constructs were gener-
ated by using a QuikChange multisite-directed mutagenesis
kit and transfected into BLM//RecQL5/ chicken DT40
cells by using nucleofection solution. 1  106 cells in pellets
were suspended into 100 l of nucleofection solution, and
2–5 g of DNA was then added to the suspended solutions.
Due to the low transfection efficiency, each construct was
digested with XhoI, and the linearized plasmids were used
for transfection. Transfected solutions were incubated for
24 h in a 6-well plate with 2.0 ml of medium. Stable clones
were isolated from the primary transfectant pools using lim-
iting dilution into 96-well plates and selection for resistance
to zeocin.
SCE Assay—The SCE assay followed the published protocol
(27, 28) with minor modifications. In brief, cell cultures were
grown through two cell cycles in the presence of 10 M 5-bro-
modeoxyuridine (BrdU). Colcemidwas added to a final concen-
tration of 0.1 g/ml to accumulate mitotic cells 2 h prior to the
harvesting of cells. Harvested cells were then treated with 75
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mMKCl for 20min at room temperature and then fixedwith 3:1
(v/v)methanol-glacial acetic acid. The fixed cell suspensionwas
dropped onto a glass slide and air-dried. The cells on the slides
were incubatedwith 10g ofHoechst 33258/ml in 50mMphos-
phate buffer (pH 6.8) for 20 min and rinsed with MacIlvaine
solution. The cells were exposed to UV for 60 min and then
incubated in 2 SSC at room temperature for 60min. The cells
were finally stained with 3% Giemsa solution for 20–40 min
and examined under a light microscope.
Camptothecin (CPT) Sensitivity Assay—This assay was done
as described (27).
HomologyModeling—Thehomologymodel was generated as
described previously (27, 29, 30).
RESULTS
RECQL5 Interacts with RAD51 through a Conserved Region—
A RAD51-interacting region has been previously identified in
RECQL5 by an in vitro assay using a series of RECQL5 frag-
ments (21). We confirmed and extended the previous analysis
in vivo by expressing a series of FLAG-tagged RECQL5 frag-
ments (Fig. 1A) in HEK-293 cells and performing immunopre-
cipitation-coupled Western blot (IP-Western) to identify the
RAD51 interaction domain. This strategy has been previously
used to identify the KIX and SRI domains as the Pol II interac-
tion domains of RECQL5 (27). We found that the region (resi-
dues 621–900) between the KIX and SRI domains is both nec-
FIGURE 1. RECQL5 interacts with RAD51 independently of the KIX and SRI domains. A, schematic diagram of the wild type and truncated forms of
FLAG-RECQL5. The N-terminal helicase, RECQ C-terminal (RQC), KIX, and SRI domains are shown along with the newly identified BRC repeat. The RAD51
interaction data are summarized on the right. B, immunoblotting shows the associations between different RECQL5 mutants and RAD51. HEK-293 cells were
transfected with expression plasmid of full-length and various RECQL5 deletion constructs. The mixtures of FLAG IP were analyzed by immunoblotting with
antibodies to FLAG and RAD51. C, sequence alignment of RECQL5 from different species. The residues mutated are marked with asterisks. All of the residues
were converted to alanine. D, IP-Western shows that different RECQL5 point mutants coimmunoprecipitated with different amounts of RAD51 but with
comparable amounts of Pol IIo and Pol IIa. The FLAG-tagged RECQL5 and its different point mutants were transfected into HEK-293 cells. Co-immunoprecipi-
tation was performed using the FLAG antibody.
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essary and sufficient for RAD51 association (Fig. 1, A and B,
lane 8). Because RAD51 is highly conserved in evolution, it
seemed likely that its binding residues in RECQL5 should also
be well conserved. Therefore, we mutagenized several con-
served residues within this region (Fig. 1C) and found that
mutant B (F666A/Q667A) substantially reduced RAD51 asso-
ciation, whereasmutantA (K651A/K653A/R654A) andmutant
C (K750A/Q752A) retained normal association (Fig. 1, C and
D). Thus, the region containing Phe-666 and Gln-667 is
required for RAD51 association, in agreement with the previ-
ous in vitro data indicating that Phe-666 and residues between
positions 652 and 674 are required for RAD51 interaction (21).
We noted that althoughmutant B has reduced association with
RECQL5, it retained normal association with Pol II (Fig. 1D),
indicating that RECQL5-RAD51 association is independent of
RECQL5-Pol II interactions.
A BRC Repeat Variant Is Present in the RAD51 Interaction
Domain of RECQL5—Sequence analysis revealed that the
RAD51 interaction domain of RECQL5 contains two conserved
motifs that are either identical or similar to those previously
described in the BRC repeat of BRCA2 (Fig. 2A) (14). For exam-
ple, the consensus sequence ofmotif 1 inRECQL5, FX(T/S)A, is
identical to the corresponding sequence of the BRC repeat
(FXXA) (Fig. 2A). In addition, themotif 2 sequence of RECQL5,
LLDE, is also similar to the consensus sequence ofmotif 2 of the
BRC repeat (hhXa, where “h” represents a hydrophobic and “a”
represents an acidic residue). Based on these observations, we
have named theRECQL5 region that encompasses the two con-
served motifs as BRCv (BRC repeat variant).
A Homology Model Predicts That BRCv Binds RAD51-like
BRC—Structure predictions suggested that RECQL5-BRCv,
like the BRCA2-BRC repeat, is largely devoid of regular second-
ary structure (31). A homology model for the RECQL5-BRCv
repeat was generated in the Swissmodel server, using the
RAD51-BRC4 structure (Protein Data Bank entry 1N0W) as
the template (29). The model predicts that the conserved Phe
and Ala side chains of the BRCv FXXAmotif 1 may make con-
tact with the hydrophobic pocket on the core catalytic domain
of RAD51, part of the oligomerization interface, as seen in the
RAD51-BRC4 structure (Fig. 2, A and C) (11). The LLDEmotif
2 of BRCv is expected to bind a region of RAD51 distant from
the oligomerization surface. The first two hydrophobic resi-
dues (Leu-700 and Leu-701) are predicted to occupy the same
pocket occupied in RAD51 by Leu-1545 and Phe-1546 of
BRCA2-BRC4, and the acidic residue in the fourth position
(Glu-703) is expected to form a salt bridge with Arg-250 of
RAD51, as seen forGlu-1548 of BRCA2-BRC4 (Fig. 2C) (11, 14).
We note that the sequence that intervenes between the two
BRCvmotifs, predicted by themodel to form a helix and a loop,
is twice the length (25 amino acids) of that of the BRCA2-BRC
repeat (12 amino acids) and therefore unique to the
RECQL5-BRCv.
Both Motifs of the BRCv Are Needed for RECQL5-RAD51
Association—A previous study has shown that both motifs of
BRCA2-BRC4 are required for RAD51 binding and BRC func-
tion (14). We investigated whether the two motifs of BRCv are
similarly required for RECQL5 to associate with RAD51 by
structure-guided mutagenesis, using the homology model
described above. In motif 1, we substituted F666E or A669E to
disrupt hydrophobic interactions at the predicted BRCv-
RAD51 interface (Fig. 2C). In motif 2, we substituted L700E or
L701E to disrupt the predicted hydrophobic interactions and
E703A to abolish the predicted salt bridge with RAD51-R250
(Fig. 2C) (11, 14). We found that each mutation substantially
reduced the amount of RAD51 that co-immunoprecipitated
with RECQL5 (Fig. 2D, lanes 2–5). The results support the
inference that both motifs are integral parts of a BRC repeat
variant and indispensable for RAD51 interaction.
We noted that RECQL5 mutants in which only one motif of
BRCv is mutated retained partial association with RAD51
(about 10–40%). We therefore generated several double
mutants that simultaneously mutate both motifs and found
that these mutants were more severely defective in RAD51
association (Fig. 2D, lanes 6–9). The data suggest that BRCv
can bind RAD51 through either motif and that only when both
motifs are inactivated is RAD51 binding abolished.
A Conserved Residue outside Motif 1 of BRCv Contributes to
RAD51 Association—In addition to the two motifs, conserved
residues next to motif 1 in BRCA2-BRC4 have also been shown
to contribute to RAD51 association (11, 14). In particular,
mutation of one of the hydrophobic residues, Val-1532, dis-
rupts BRCA2-RAD51 association (32). We found that the cor-
responding residue of Val-1532 in BRCv is highly variable in
RECQL5 from different species (Fig. 2A), indicating that this
residue in BRCv is dispensable for RAD51 association. In con-
trast, BRCv has two highly conserved hydrophobic residues
next to motif 1, Leu-672 and Met-673. Substitution of Leu-672
with Ala substantially reduced RECQL5-RAD51 association
(supplemental Fig. S1), consistent with the notion that residues
outside of motif 1 also contribute to RAD51 association.
Motif 1 of BRCv Is More Important than Motif 2 for Suppres-
sion of D-loop Formation—RECQL5 has been shown to possess
anti-recombinase activity, evidenced by its ability to inhibit
RAD51-mediatedD-loop formation (20). This activity was later
shown to be decreased in two mutants localized in motif 1:
F666A, which substituted the conserved Phe in the FX(T/S)A
consensus sequence, and 652–674, in which motif 1 was
deleted (21). We studied whether one or both motifs of BRCv
are required for the anti-recombinase activity of RECQL5,
using the same D-loop assay (20). For this purpose, we
expressed and purified several recombinant RECQL5 mutant
proteins from E. coli that harbored mutations in either motif 1
(F666E) or 2 (L700E and E703E) or in both (F666E/L700E and
F666E/E703A) (Fig. 3A). All threemutant proteins behaved like
thewild type counterpart during purification and hadwild-type
levels of ATPase activity (Fig. 3B).
We found that whereas the wild type RECQL5 protein inhib-
ited D-loop formation efficiently, the motif 1 mutant was defi-
cient in this activity (Fig. 3, C–E). The result is in agreement
with published data (21). In contrast, the results showed that
the two motif 2 mutants are less affected in their D-loop inhib-
itory activity. As expected, the two variants with mutations in
both motifs were more deficient in D-loop inhibitory activity
(Fig. 3, C–E). These results indicate that although both motifs
of the BRCv are required for optimal association between
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FIGURE 2.Asingle BRC repeat variant in RECQL5 is essential for RAD51 interaction.A, sequence alignment showing similarities betweenBRCvs of RECQL5
fromdifferent species and theeight BRC repeats of humanBRCA2.Motif 1 andmotif 2 are shownby red andgreen, respectively,with their consensus sequences
shown at the top. The asterisks indicate a key conserved residue in the linker region that is also important for RAD51 association, but this residue is located at
different positionsbetweenBRCvandBRC. Ablue divider in themiddle is used tohighlight thedifference in lengthof linker sequencesbetweenBRCA2-BRCand
RECQL5-BRCv. The number of linker residues is shown in brackets. The species include human (HOMSA), mouse (MUSMU), chicken (GALGA), Xenopus (XENTR),
fish (FUGRI), and Drosophila (DROME1 and DROME2). Notably, Drosophila RECQL5 has two potential BRCvs, whereas that from other species has only one. B,
sequence alignment of putative BRCvs identified in four helicases (Srs2, Mph1, Sgs1, and Pif1) from different yeast species. The asterisks indicate the residues
mutated to alanine.C, homologymodel of the RECQL5-BRC repeat. RAD51-BRC4 (BRCA2) (ProteinData Bank entry 1N0W) is shownoverlaidwith thehomology
model of RECQL5-BRCv. Cyan, RAD51; orange, BRCA2-BRC4; green, RECQL5-BRCv. Residues associated with motif 1 and motif 2 are shown in stick representa-
tions and labeled accordingly. D, IP-Western shows that RECQL5 with mutations in either motif 1 or 2 co-immunoprecipitated with reduced levels of RAD51,
whereas that with mutations in both motifs almost completely lost RAD51 association. The numbers below lanes 1–5 indicate relative levels of RAD51 that
co-immunoprecipitated with an indicated RECQL5 mutant, with the wild type protein being set as 1.0.
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RECQL5 and RAD51, motif 1 is more essential for anti-recom-
binase function, withmotif 2 seeming to play only a minor role.
Both Motifs of BRCv Are Required by RECQL5 to Suppress
SCE—Using a trans-dominant negative assay in human HEK-
293 cells, a small difference (about 15–20%) has been previously
observed between a RECQL5motif 1mutant (F666A) andwild-
type protein in the down-regulation of HR-dependent repair of
double strand breaks (21). One caveat of this assay is that the
exogenous protein needs to be overexpressed to a level signifi-
cantly higher than that of the endogenous protein. To circum-
vent this requirement, we utilized RECQL5-knock-out chicken
DT40 cells (18, 27) to investigate whether the conservedmotifs
of BRCv are needed for RECQL5 to promote genome stabiliza-
tion in vivo. Because RECQL5 and BLMare functionally redun-
dant in DT40 cells (RECQL5/ single mutant cells lack obvi-
ous genome instability phenotypes), we studied functions of
RECQL5 in RECQL5//BLM/ double mutant cells, which
exhibit a higher SCE frequency and CPT sensitivity compared
with BLM/ single mutant cells (18, 27). We have previously
shown that reintroduction of wild type RECQL5 protein into
RECQL5//BLM/ cells restored theSCEfrequencyandCPT
sensitivity to those of theBLM/ cells,whereas reintroductionof
RECQL5mutantsdeficient in associationwithRNApolymerase II
failed to fully rescue (27). Here we used the same RECQL5//
BLM/ mutant cells to study whether various RECQL5-BRCv
mutants (Fig. 4A) can correct these phenotypes.
All mutants were expressed at levels comparable with that of
the wild-type protein (supplemental Fig. S2). In addition, all
four variants with single-motif mutations in BRCv associated
with RAD51 at reduced levels by IP-Western, and those with
mutations in both motifs associated with little or no RAD51
(supplemental Fig. S2, lanes 1–8). These results are in agree-
ment with the finding that bothmotifs of BRCv are required for
normal association with RAD51 in human cells (Fig. 2D, lanes
6–9).
Wenoticed that the levels of RAD51 that associatewith three
single mutants (F666E, A669E, and L700E) were somewhat
higher than those observed in human cells (compare Supple-
mental Fig. S2, lanes 2–4, with Fig. 2D, lanes 2–4). This could
be due to the use of human proteins in chicken cells, so that the
observed RECQL5-RAD51 association could be somewhat dif-
ferent compared with that in human cells.
As reported before (18, 27), the SCE level of RecQL5//
BLM/ cells was found to be significantly higher than that of
BLM/ cells (28.8 versus 18.8), and this enhanced level of SCE
was completely suppressed by reintroduction of wild type
RECQL5 protein (Fig. 4, A and B). In this assay, lower SCE
suppression efficiency correlates with a stronger protein defect,
with the suppression efficiency of the wild type protein being
set as 100%. Reintroduction of either motif 1 or 2 mutants par-
tially suppressed the enhanced SCE levels of RecQL5//
BLM/ cells. Suppression efficiency ranged from 34–47% for
the two motif 1 mutants (F666E and A669E) to 67–81% for the
two motif 2 mutants (L700E and E703A). Transfection of the
variants with mutations in both motifs (F666E/L700E, A669E/
L700E, and F666E/E703A) resulted in SCE suppression effi-
ciency that was lower than that seen with single mutants; the
level of SCE in cells that expressed these compound mutants
was statistically indistinguishable from that of RecQL5//
BLM/ cells (Fig. 4,A and B). These results are in accord with
FIGURE 3. RECQL5-RAD51 interaction mediated by BRCv motif 1 is critical for the suppression of D-loop formation. A, I, purification scheme for
recombinant RECQL5protein expressed in E. coli. II, the purifiedWTandmutant RECQL5proteinswere resolvedby 10%SDS-PAGE and stainedwith Coomassie
Blue. B, a graph shows ATPase activity of RECQL5 and its various point mutants. C, a schematic diagram shows the D-loop reaction scheme. D, an autoradio-
graph shows effects of RECQL5 and itsmutants on RAD51-mediatedD-loop formation. The radiolabeled single-strandedDNA and theD-loop are indicated on
the left. The presence () or absence () of RECQL5 and its variousmutants is shown at the top. E, quantification of the D-loop assay. Mean S.D. values (error
bars) from at least three independent experiments are plotted.
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the RAD51 binding data in Fig. 2, indicating that the RECQL5-
RAD51 interactions mediated by both motifs of BRCv are
required for optimal suppression of SCE. The observations that
the twomotif 1 mutants are more deficient in SCE suppression
than the two motif 2 mutants correlate well with the D-loop
inhibition data (Fig. 3) and suggest that motif 1 is more impor-
FIGURE 4. RECQL5 mutants deficient in RAD51 interaction are defective in suppression of SCE and resistance to CPT. A, summary of different human
RECQL5 mutants and their corresponding activities in association with RAD51, ATPase activity, Pol IIa binding, and suppression of SCE. Different RAD51
association is indicated as follows., normal;, reduced;, nearly completely lost. SCE values are shownas a percentage. The suppression efficiency for the
wild type protein was set to 100%. Lower suppression efficiency correlates with stronger defect. n.s, statistically not significantly different from the BLM//
RecQL5/ cells. B, scatter plot showing the SCE levels of BLM//RecQL5/ DT40 cells complemented by the wild type and various mutants of RECQL5 as
shown in A. Each point represents the total number of SCEs in a singlemitotic spread. Conditions that show significant differences of p value0.05 or p value
0.0001 are shown as one or three asterisks, respectively. The mean number of SCEs/cell is shown for each mutant, which was determined by examining
chromosome spreads of three independent groups of metaphase cells (50 cells per group). C and D, CPT sensitivity curves of BLM//RecQL5/ DT40 cells
complemented with WT and different RECQL5mutants, as indicated. Two different clones were tested for each mutant in order to ensure that the results are
not due to clonal variation. Mean and S.D. (error bars) from three independent experiments are shown.
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tant than motif 2 for RECQL5 to regulate RAD51 activity dur-
ing HR in vivo.
Both Motifs of BRCv Are Required by RECQL5 to Promote
Cellular Resistance to CPT-induced Replication Stress—We
studied whether RECQL5 mutants carrying mutations in dif-
ferent motifs of BRCv are defective in promoting resistance to
CPT-induced replication stress. Consistent with our previous
findings, introduction of human RECQL5 into RecQL5//
BLM/ DT40 cells largely corrected the hypersensitivity of
these cells to CPT (Fig. 4C) (27). Importantly, RECQL5 variants
carrying mutations in either motif 1 (F666E and A669E) or
motif 2 (L700E and E703A) were only partially active in rescu-
ing the hypersensitivity toCPT,whereas variants carrying com-
bined mutations in both motifs (F666E/E703A, F666E/L700E,
A669E/L700E) were more deficient than single motif mutants
in this assay (Fig. 4, C and D, and supplemental Fig. S3). These
results correlate with the degree of RAD51 binding (Fig. 2D) by
revealing that RECQL5 variants with single-motif mutations
bound reduced amounts of RAD51 and partially supported
CPT resistance, whereas variants withmutations in bothmotifs
weremore deficient in RAD51 binding and thusmore defective
in supporting CPT resistance. The results are also consistent
with the SCE data and again suggest that both motifs of BRCv
are required for the normal function of RECQL5 during
genome stabilization.
BRCv Is Needed in Genome Maintenance Pathways Depend-
ent on theHelicase Activity or theKIXDomain of RECQL5—We
have previously shown that RECQL5 with mutations in either
the helicase domain (K58R,which inactivates the helicase activ-
ity) or the KIX domain (E584D, which disrupts associationwith
Pol IIa) were partially deficient in correcting the higher SCE
level and CPT hypersensitivity of RecQL5//BLM/ cells,
whereas RECQL5 with mutations in both domains was com-
pletely deficient, suggesting that these two domains are needed
for the integrity of different genome maintenance pathways
(27). We investigated whether the helicase- and KIX-depen-
dent pathways require BRCv. For this purpose, we generated a
mutant that compromises the BRCv and helicase function
(K58R/F666E/E703A) and another that inactivates both the
BRCv and KIX domain (E584D/F666E/E703A). IP-Western
confirmed that these two mutants were as deficient in RAD51
association as the BRCv mutant (F666E/E703A). Importantly,
neither the helicase nor the KIX domain mutation affected
RAD51 binding (supplemental Fig. S2, lanes 9, 10, and 12).
We found that the SCE level and CPT sensitivity of Rec-
QL5//BLM/ cells expressing the BRCv-helicase double
mutant were higher (i.e. more functionally impaired) than those
cells complemented by the helicase single mutant but were
comparable with those cells complemented by the BRCv
mutant (Fig. 5,A andB; also see Fig. 4A). Similarly, the SCE level
and CPT sensitivity of cells expressing the BRCv-KIX double
mutant were higher than those of cells complemented by the
KIX single mutant but were comparable with those of cells
complemented by the BRCv mutant (Fig. 5, A and C; also see
Fig. 4A). These results suggest that both the helicase- and KIX
domain-dependent genome maintenance pathways require
BRCv to function.
Potential BRCvs Are Present in Other HR Regulatory Proteins—
One implication of our studies is that BRCv may be utilized by
proteins other than RECQL5 to regulate HR. When we
searched protein databases with consensus sequences of the
twoBRCvmotifs, we identified potential BRCvmotifs in several
HR regulatory proteins, including yeast helicases Sgs1, Srs2,
Mph1, and Pif1 (see Fig. 2B). Interestingly, the first three heli-
cases all have anti-recombinase activities similar to that of
RECQL5, including disruption of RAD51-made D-loops and
suppression of crossover recombination (20, 24, 25, 33, 34). The
data imply that the predicted BRCv motifs in these helicases
may play a similar role in modulating the interaction with
Rad51 as does the BRCv motif of RECQL5.
A Predicted BRCv Motif in Srs2 Is Critical for RAD51 Associ-
ation and Suppression of D-loop Formation—One of the puta-
tive BRCv motifs in Srs2 (see Fig. 2B) is located within the
Rad51-binding region that has been previously mapped (resi-
dues 783–1038) (35). To study whether this BRCv is important
for Srs2 to bind Rad51 and suppress HR, we mutated two resi-
dues that are highly conserved in RECQL5-BRCv motifs and
critical for RECQL5 to bind RAD51: one within the predicted
motif 1 (F837A) and the other just outside of the motif 1
(L844A) (see Fig. 2B). The Srs2 wild type and mutant proteins
were expressed in E. coli, purified to near homogeneity (Fig.
6A), and analyzed for RAD51 association as described above for
RECQL5. Both mutants had ATPase activity similar to that of
the wild type protein (Fig. 6B), indicating that the proteins are
folded properly. Importantly, the mutant L844A was strongly
deficient in both Rad51 interaction (Fig. 6C) and inhibition of
Rad51-mediated D-loop formation (Fig. 6, D and E), whereas
themutant F837Awas largely normal in Rad51 association (Fig.
6C) but was modestly defective in suppression of D-loop for-
mation at low protein concentrations (the suppression was
about 70% for thewild type and 58% for the F837Amutant) (Fig.
6, D and E; compare lanes 5 and 3). Overall, these data support
our prediction that a BRCv is present in Srs2, and this motif is
critical for Srs2 to bind Rad51 and inhibit D-loop formation.
DISCUSSION
ABRCRepeat Variant in RECQL5 and Srs2Mediates RAD51
Association—Although the BRC repeat had not been found in
proteins other than BRCA2, we demonstrated that an HR reg-
ulatory protein, RECQL5, possesses a BRC repeat variant
(BRCv) that resembles the BRCA2-BRC repeat in terms of
structure and interaction motifs. Notably, both BRCv and BRC
comprise two conserved motifs separated by a linker sequence,
and the consensus sequence is identical for motif 1 and very
similar for motif 2. Moreover, the two motifs in BRCv, as has
been documented for BRC (14), are required for optimal
RAD51 association; mutations in eithermotif reduce the ability
of RECQL5 to bind RAD51, to inhibit RAD51-mediatedD-loop
formation, to suppress SCE, and to resist CPT-induced repli-
cation stress. Notably, using BRCv consensus sequences to
search protein databases, we identified potential BRCv
motifs in other HR regulatory proteins (Fig. 2B). We showed
that a point mutant (L844A) in the predicted BRCv of Srs2 is
strongly deficient in both Rad51 association and D-loop
inhibition (Fig. 6). Our findings thus expand the role of the
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BRC repeat beyond BRCA2 and its orthologs. This strength-
ens the inference that the BRCv-mediated RAD51 associa-
tion is important for HR regulation in general. Although the
data presented herein indicate that the BRCv regulates interac-
tion with Rad51 to mediate the anti-recombinase function of
helicases, it remains an intriguing possibility that thismotifmay
also promote Rad51 interaction in a prorecombination role
under other circumstances.
We note that RECQL5 and several other vertebrate helicases
(FBH1, RTEL1, and PARI) have been proposed to be function-
ally equivalent to yeast Srs2 (20, 36–38). Our finding that Srs2
contains a functional BRCv favors RECQL5 as the Srs2 equiva-
lent in humans.
BRCv and BRC Have both Common and Unique Features—
The structural and functional similarities between BRCv and
BRC suggest that the two domains may engage the same
epitope onRAD51. For example,motif 1 of BRCv is predicted to
bind the same RAD51 oligomerization interface (86FXXA89) as
does motif 1 of BRC, which is expected to interfere with a cru-
cial contact between RAD51 monomers to prevent RAD51 fil-
ament formation (11). On the other hand, motif 2 in BRCv is
expected to interact with a pocket on RAD51 that is distant
from the oligomerization surface (11, 14). In support of this
model, RECQL5 motif 1 mutants are deficient in inhibiting
RAD51-mediated D-loop formation, whereas RECQL5 motif 2
mutants have reduced, albeit still significant, inhibitory activity.
Moreover, motif 1mutants of RECQL5 aremore defective than
motif 2 mutants in SCE suppression. These data suggest that
interaction mediated by motif 1 at the RAD51 oligomerization
interface is more important in regulating RAD51 activity than
interaction by motif 2 at the distant pocket. This may help to
rationalize the observation that motif 1 is strictly conserved in
RECQL5 orthologs through evolution, whereas motif 2 is not
(Fig. 2A).
BRCv and BRC nevertheless differ from one another in sev-
eral ways. First, the residues near motif 1 are different (Fig. 2A)
between the two. In the BRCA2-BRC repeats, hydrophobic res-
idues scattered in the linker between motif 1 and motif 2 are
required for the interaction between the linker and RAD51 as
the repeat wraps around RAD51 (11, 14, 32). This hydrophobic
patch is not found in RECQL5-BRCv. Likewise, a pair of hydro-
phobic residues conserved in the RECQL5-BRCv immediately
adjacent to the FXXAmotif 1 are not found in the BRCA2-BRC
repeats. One of these residues (Leu-672) is also conserved in
Srs2-BRCv (Leu-844), and mutation of this residue in either
RECQL5 or Srs2 substantially reduces RAD51 association.
Thus, interactions with RAD51 outside the two primary motifs
appear to be different for BRCv versus BRC. Second, the linker
FIGURE5.RECQL5BRCvacts in the samepathwayeitherwith thehelicaseor theKIXdomain to suppressSCEand resistCPT-induced replication stress.
A, scatter plot showing the SCE levels ofBLM//RecQL5/DT40 cells complementedby variousmutants of RECQL5, as indicated. See the legend to Fig. 4. The
meanSCEnumbers are indicated for eachmutant.B andC, CPT sensitivity curves ofBLM//RecQL5/DT40 cells complementedwithWTor different RECQL5
mutants, as indicated. D, model to illustrate how different domains of RECQL5 may work together to promote genome stabilization. Error bars, S.D.
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sequences between the two motifs are different; the length in
BRC is constant (12 residues), whereas that in BRCv is highly
variable and also longer (18–25 residues) (Fig. 2A). The extra
residues in BRCv are of unknown significance. Third, whereas
BRC exists in multiple copies in human BRCA2, BRCv is pres-
ent as a single copy in RECQL5 frommost species. It was shown
that BRC repeats within BRCA2 can be classified into two
groups that have complementary functions and can work syn-
ergistically to activate HR (39). Speculatively, a single copy of
BRCv may be sufficient for HR suppression, whereas coopera-
tive interactions by multiple BRC repeats could be required for
optimal activation of HR. Interestingly, Drosophila RECQL5
contains two putative BRCv repeats (Fig. 2A), hinting that
BRCv may also function in tandem as seen in BRCA2-BRC.
Wenoted that themotif 1mutant of Srs2-BRCv is onlymildly
defective in D-loop inhibition and is indistinguishable in Rad51
association compared with the wild type protein (Fig. 6). This
differs from the motif 1 mutant of RECQL5 that is strongly
defective in both assays (Fig. 2) (21). The data imply that Srs2
may be less dependent onmotif 1-mediated Rad51 interactions
compared with RECQL5.
Two Pathways Mediated by Helicase and KIX Domains Con-
verge to Regulate BRCv-mediated Recombination—Previously,
several functional domains were identified in RECQL5: the
helicase domain that is involved in DNA translocation and the
KIX and SRI domains that mediate the association with differ-
ent forms of RNAPol II (27, 40). The findings here add BRCv as
a newdistinct functional domain that enables RECQL5 to inter-
act with RAD51. How do these different domains and their
associated activities cooperate to accomplish RECQL5 func-
tions? Our previously reported double mutant analyses have
shown that the helicase and KIX domains act in independent
pathways (27), whereas here we demonstrated that the BRCv is
needed for the functional integrity of both pathways that are
dependent on either the helicase or KIX domain. We suggest
that BRCv-mediated RAD51 association may represent a com-
mon denominator of the two pathways that suppress SCE and
confer resistance to CPT-induced replication stress (Fig. 5D).
Although it seems likely that the helicase activity allows
RECQL5 to translocate on DNA and dissociate RAD51 mono-
mers fromDNA in a processive fashion, it remains unclear how
KIX affects BRCv-dependent RAD51 regulation. One possibil-
ity is that when the helicase/DNA translocase activity of
RECQL5 is inactivated, the KIX-associated Pol II may recruit a
backuphelicase to power the translocation of RECQL5onDNA
in order to effect RAD51 removal.
In summary, our results suggest that the BRC repeat could be
a general RAD51 regulatory module that can be used to either
promote HR, as in the case of BRCA2, or repress HR, as in the
case of RECQL5.
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